Effect of ibuprofen on cardioprotective effect of aspirin

Lancet

Volumn 361, Issue 9357, 2003, Pages 573-574

  MacDonald, T M ^a   Wei, L ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART PROTECTION; HUMAN; LOW DRUG DOSE; MORTALITY; PRIORITY JOURNAL; RISK; SURVIVAL;

EID: 0037442182     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12509-3     Document Type: Article

References (4)

1. Catella-Lawson F., Reilly M.P., Kapoor S.C., et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 345:2001;1809-1817.
2. Evans J.M., MacDonald T.M. Record-linkage for pharmacovigilance in Scotland. Br J Clin Pharmacol. 47:1999;105-110.
3. Ghali W.A., Quan H., Brant R., et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA. 286:2001;1494-1497.
4. Ray W.A., Stein C.M., Hall K., Daugherty J.R., Griffin M.R. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet. 359:2002;118-123.